From Molecular Insights to Clinical Impact: Translating the Latest Advances in Menin Inhibitors Into Practice

Highlights from the PER® CME activity "From Molecular Insights to Clinical Impact: Translating the Latest Advances in Menin Inhibitors Into Practice" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.

In this podcast, experts Naval G. Daver, MD; Amir Fathi, MD; Guillermo Garcia-Manero, MD; and Aditi Shastri, MD, discuss current applications for menin inhibitors in patients with acute leukemia, combination approaches under investigation, and managing treatment-related adverse events with menin inhibitors.

Earn CME credit by completing the full accredited activity (available through April 27, 2027):
https://www.gotoper.com/molecularinsights26menin-activity

This podcast, including the narration, was developed by PER® (Physicians’ Education Resource®, LLC) editorial staff from the full online CME activity developed with these faculty. The narration was voiced by a PER staff member or by an AI tool. The podcast contains no product advertising. The full activity is supported by educational grants from Kura Oncology and Syndax Pharmaceuticals, Inc.

This content is for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Faculty may discuss investigational or off-label uses; consult prescribing information for any products discussed.